Clinical trial
The Breast Program - Translational Cancer Resource
NCT02798341 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Breast Program - Translational Cancer Resource
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 31, 2012
- Completion date
- July 31, 2030
- Enrollment
- 4,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer